REGENERON PHARMACEUTICALS, INC. Deferred Tax Assets, Property, Plant and Equipment
REGENERON PHARMACEUTICALS, INC. (REGN) had Deferred Tax Assets, Property, Plant and Equipment of $192.60 million as of 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2026-02-04
- 2025-12-31: Deferred Tax Assets, Property, Plant and Equipment $192.60M.
- 2024-12-31: Deferred Tax Assets, Property, Plant and Equipment $145.10M.
- 2023-12-31: Deferred Tax Assets, Property, Plant and Equipment $154.80M.
- 2022-12-31: Deferred Tax Assets, Property, Plant and Equipment $227.60M.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $192.60M 10-K · filed 2026-02-04 |
| 2024-12-31 | $145.10M 10-K · filed 2026-02-04 |
| 2023-12-31 | $154.80M 10-K · filed 2025-02-05 |
| 2022-12-31 | $227.60M 10-K · filed 2024-02-05 |
| 2021-12-31 | $257.50M 10-K · filed 2023-02-06 |
| 2020-12-31 | $140.50M 10-K · filed 2022-02-07 |
| 2019-12-31 | $192.00M 10-K · filed 2021-02-08 |
| 2018-12-31 | $107.80M 10-K · filed 2020-02-07 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-07 |
| 2016-12-31 | $21.14M 10-K · filed 2018-02-08 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-09 |
| 2014-12-31 | $8.08M 10-K · filed 2016-02-11 |
| 2013-12-31 | $18.90M 10-K · filed 2015-02-12 |
| 2012-12-31 | $1.38M 10-K · filed 2014-02-13 |
| 2011-12-31 | $14.85M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |